Global /South Korea /Healthcare /Medical Devices /039860

NanoEntek, Inc.

039860

• KRX: 039860 • Delayed

7,350KRW 30%

4.80 USD

As of 5 June 2026, NanoEntek, Inc. has a market cap of $182.14M USD, ranking #21669 globally and #873 in South Korea. It ranks #1949 in the Healthcare sector, and #402 in the Medical Devices industry.

Global Rank

21669

Country Rank

873

Sector Rank

1949

Industry Rank

402

Key Stats

Market Cap

$182.14MUSD

279.98B KRW

Enterprise Value

$153.33MUSD

235.03B KRW

Revenue (TTM)

$24.81MUSD

38.13B KRW

EBITDA (TTM)

$2.95MUSD

4.52B KRW

Net Income (TTM)

$1.03MUSD

1.58B KRW

EBITDA Margin

12%

Profit Margin

4.1%

PE Ratio

156.4

PS Ratio

7.3

PB Ratio

3.1

EV/EBITDA

52.0

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Medical Devices

CEO

Jin-Hyung Park open_in_new

Employees

Founded

1987

Website

nanoentek.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
30%	8.4%	-32%	12%	71%	-5.7%	61%	12%	-50%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	039860 (주)나노엔텍 ISIN: KR7039860002 Shares Out.: Shares Outstanding: 37.844M¹ Shares Float: 21.108M² TV: TradingView: KRX: 039860 SA: Stock Analysis: KRX: 039860 YF: Yahoo Finance: 039860.KS GF: Google Finance: KRX: 039860 BA: Barron's: 039860 MS: Morningstar: XKRX: 039860	7,350 KRW	TV: TradingView: KRX: 039860 SA: Stock Analysis: KRX: 039860 YF: Yahoo Finance: 039860.KS GF: Google Finance: KRX: 039860 BA: Barron's: 039860 MS: Morningstar: XKRX: 039860

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About NanoEntek, Inc.

NanoEntek, Inc. engages in the research and development, production, and sale of life-science lab equipment, in vitro diagnostic medical devices, point of care diagnostic devices, and related consumables and solutions in Korea and internationally. It provides FREND system, a fluorescence immunoassay analyzer; BUDDI, a rapid diagnostic test analyzer; rapid diagnostic test items; ADAM-rWBC, a residual white blood cell counters; ADAMII/fluorescence stem cell counter; fluorescence cell counters and cell analyzers; brightfield cell counters; somatic cell counters; live-cell imaging system; and disposable hemocytometers. The company also provides digital healthcare services integrating artificial intelligence and big data technologies. The company was founded in 1987 and is headquartered in Seoul, South Korea.

Similar Companies

Industry: Medical Devices (South Korea)

Name	Market Cap (USD) diff.	PE	Country
CLASSYS Inc. KRX: 214150	$2.44B 3.75T KRW 1K%	28.7	South Korea
SEERS Co., Ltd. KRX: 458870	$1.21B 1.86T KRW 566%	114.8	South Korea
Livsmed Inc. KRX: 491000	$1.18B 1.81T KRW 546%	-	South Korea
L&C BIO Co.,LTD KRX: 290650	$1.13B 1.74T KRW 520%	-	South Korea
Seegene, Inc. KRX: 096530	$751.49M 1.16T KRW 313%	23.9	South Korea
i3system Inc. KRX: 214430	$526.7M 809.64B KRW 189%	83.3	South Korea

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 95K%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 88K%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 87K%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 69K%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 66K%	38.3	United States
Medtronic plc NYSE: MDT	$101.9B 56K%	22.2	Ireland

chevron_leftBack